Social inclusion and hepatitis C: exploring new possibilities for prevention

References

• Aceijas C, Rhodes T. Global estimates of prevalence of HCV infection among injecting drug users. Int. J. Drug Policy18, 352–358 (2007).
   PubMed Web of Science ®Google Scholar
• National Centre in HIV Epidemiology and Clinical Research. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia. Annual Surveillance Report 2009. McDonald A (Ed.). National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia (2009).
   Google Scholar
• Razali K, Thein H, Bell J et al. Modelling the hepatitis C virus epidemic in Australia. Drug Alcohol Depend.91(2–3), 228–235 (2007).
   PubMed Web of Science ®Google Scholar
• Maher L, Li J, Jalaludin B, Chant K, Kaldor J. High hepatitis C incidence in new injecting drug users: a policy failure? Aust. NZ J. Public Health31(1), 30–35 (2007).
   PubMed Web of Science ®Google Scholar
• Griew R, Jackson N, van Beek I, Maher L, Malcolm A. Review of evidence on interventions to reduce the incidence of hepatitis C infection. Australian Health Ministers’ Advisory Council, Canberra, Australia (2008).
   Google Scholar
• Cook C. Introduction. In: The Global State of Harm Reduction 2010: Key Issues for Broadening the Response. Cook C (Ed.). International Harm Reduction Association, London, UK, 5–6 (2010).
   Google Scholar
• National Centre for HIV Epidemiology and Clinical Research. Return on Investment 2: Evaluating the Cost–Effectiveness of Needle and Syringe Programs in Australia 2009. National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia (2009).
   Google Scholar
• Bryant J, Hopwood M. Secondary exchange of sterile injecting equipment in a high distribution environment: a mixed method analysis in south east Sydney, Australia. Int. J. Drug Policy20, 324–328 (2009).
   PubMed Web of Science ®Google Scholar
• Snead J, Downing M, Lovrick J et al. Secondary syringe exchange among injection drug users. J. Urban Health80(2), 330–48 (2003).
   PubMed Web of Science ®Google Scholar
• Tyndall M, Bruneau J, Brogly S, Spittal P, O’Shaughnessy M, Schechter M. Satellite needle distribution among injection drug users: policy and practice in two Canadian cities. J. Acquir. Immune Defic. Syndr.31, 98–105 (2002).
   PubMed Web of Science ®Google Scholar
• Davis M, Rhodes T. Managing seen and unseen blood associated with drug injecting: implications for theorising harm reduction for viral risk. Int. J. Drug Policy15, 377–384 (2004).
   Google Scholar
• Treloar C, Fraser S. Hepatitis C, blood and models of the body: new directions for public health. Crit. Public Health14(4), 377–389 (2005).
   Google Scholar
• Commission of the European Communities. Background Report: Social Exclusion – Poverty and Other Social Problems in the European Community. Office for Official Publications of the European Communities, Luxembourg (1993).
   Google Scholar
• Farmer P. Social scientists and the new tuberculosis. Soc. Sci. Med.44(3), 347–358 (1997).
   PubMed Web of Science ®Google Scholar
• Marmot M. Understanding social inequalities in health. Perspect. Biol. Med.46(3), S9–S23 (2003).
   PubMed Web of Science ®Google Scholar
• Social Exclusion Unit. Social Exclusion Unit: Purpose, Work, Priorities and Working Methods. Cabinet Office, London, UK (1997).
   Google Scholar
• Department of the Prime Minister and Cabinet. A Stronger, Fairer Australia – A New Social Inclusion Strategy. Commonwealth of Australia, Canberra, Australia (2009).
   Google Scholar
• Social Protection Committee. Joint Report on Social Protection and Social Inclusion. Social Protection Committee, Council of the European Union, Brussels, Belgium (2010).
   Google Scholar
• Saunders P, Naidoo Y, Griffiths M. Towards new indicators of disadvantage: deprivation and social exclusion in Australia. Aust. J. Soc. Issues43(2), 175 (2008).
   Web of Science ®Google Scholar
• Arthurson K, Jacobs K. A critique of the concept of social exclusion and its utility for Australian social housing policy. Aust. J. Soc. Issues39(1), 25–41 (2004).
   Web of Science ®Google Scholar
• Pollitt C. Joined-up government: a survey. Political Studies Review1(1), 34–49 (2003).
   Google Scholar
• Alcock P. Participation or pathology: contradictory tensions in area-based policy. Social Policy and Society3(2), 87–96 (2004).
   Google Scholar
• Atkinson A, Hills J. Exclusion, Employment and Opportunity. Centre for Analysis of Social Exclusion, London, UK (1998).
   Google Scholar
• Levitas R, Pantazis C, Fahmy E, Gordon D, Lloyd E, Patsios D. The Multi-Dimensional Analysis of Social Exclusion. Townsend Centre for the International Study of Poverty and Bristol Institute for Public Affairs, University of Bristol, Bristol, UK (2007).
   Google Scholar
• Hayes A, Gray M, Edwards B. Social Inclusion: Origins, Concepts and Key Themes. Paper prepared for the Social Inclusion Unit, Department of the Prime Minister and Cabinet. Commonwealth of Australia, Canberra, Australia (2008).
   Google Scholar
• Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend.88, 188–196 (2007).
   PubMed Web of Science ®Google Scholar
• Anti-Discrimination Board of New South Wales. C-Change: Report of the Enquiry into Hepatitis C Related Discrimination. Anti-Discrimination Board of New South Wales, Sydney, Australia (2001).
   Google Scholar
• Crofts N, Louie R, Loff B. The next plague: stigmatization and discrimination related to hepatitis C virus infection in Australia. Health Hum. Rights2, 87–96 (1997).
   PubMedGoogle Scholar
• Day C, Ross J, Dolan K. Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination? Drug Alcohol Rev.22, 317–321 (2003).
   PubMed Web of Science ®Google Scholar
• Habib S, Adorjany L. Hepatitis C and injecting drug use: the realities of stigmatisation and discrimination. Health Education J.62(3), 256–265 (2003).
   Google Scholar
• Hopwood M, Treloar C, Bryant J. Hepatitis C and injecting-related discrimination within healthcare in New South Wales, Australia. Drugs (Abingdon Engl.)13, 61–75 (2006).
   Google Scholar
• Loveday S, Treloar C, Elek C, Steele M, Hopwood M. Discrimination to the consumer. In: HIV and Viral Hepatitis: Legal, Ethical and Human Rights Issues. Medicine. ASfH (Ed.). Australian Society for HIV Medicine, Sydney, Australia (2005).
   Google Scholar
• Martin S. Reconceptualising social exclusion: a critical response to the neoliberal welfare reform agenda and the underclass thesis. Aust. J. Soc. Issues39(1), 79–94 (2004).
   Web of Science ®Google Scholar
• Tedeschi R, Kilmer R. Assessing strengths, resilience, and growth to guide clinical interventions. Prof. Psychol. Res. Pr.36(3), 230–237 (2005).
   Web of Science ®Google Scholar
• Bonanno GA. Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events? Am. Psychol.59, 20–28 (2004).
   PubMed Web of Science ®Google Scholar
• Epstein MH, Sharma JM. Behavioral and Emotional Rating Scale: A Strength-Based Approach to Assessment. Pro-Ed, Austin, TX, USA (1998).
   Google Scholar
• Mateu-Gelabert P, Treloar C, Agullo V et al. How can hepatitis C be prevented in the long-term? Int. J. Drug Policy18, 338–340 (2007).
   PubMed Web of Science ®Google Scholar
• Harris M, Treloar C, Maher L. Staying safe from hepatitis C: engaging with multiple priorities. Qual. Health Res. (2011) (In Press).
   Google Scholar
• Scambler G, Hopkins A. Being epileptic: coming to terms with stigma. Sociol. Health Illn.8, 26–43 (1986).
   Web of Science ®Google Scholar
• Goffman E. Stigma: Notes on the Management of Spoiled Identity. Penguin, Harmondsworth, UK (1968).
   Google Scholar
• Mateu-Gelabert P, Sandoval M, Meylakhs P, Wendel T, Friedman S. Strategies to avoid opiate withdrawal: implications for HCV and HIV risks. Int. J. Drug Policy21(3), 179–185 (2010).
   PubMed Web of Science ®Google Scholar
• Treloar C, Laybutt B, Jauncey M et al. Broadening discussions of “safe” in hepatitis C prevention: analysis of video recordings of injecting practice. Int. J. Drug Policy19, 59–65 (2008).
   PubMed Web of Science ®Google Scholar
• Hopwood M, Treloar C. Resilient coping: applying adaptive responses to prior adversity during treatment for hepatitis C infection. J. Health Psychol.13, 17–27 (2008).
   PubMed Web of Science ®Google Scholar
• McArthur M. Pushing the drug debate: The media’s role in policy reform. Aust. J. Soc. Issues34(2), 149–165 (1999).
   Web of Science ®Google Scholar
• Elliott A, Chapman S. ‘Heroin hell of their own making’: construction of heroin users in the Australian press 1992–97. Drug Alcohol Rev.19, 191–201 (2000).
   Web of Science ®Google Scholar
• Treloar C, Holt M. Deficit models and divergent philosophies: service providers’ perspectives on barriers and incentives to drug treatment. Drugs (Abingdon Engl.)13(4), 367–382 (2006).
   Google Scholar
• Treloar C, Byron P, McCann P, Maher L. “Fitness for duty”: social, organisational and structural influences on the design and conduct of candidate hepatitis C vaccine trials involving people who inject drugs. Vaccine28(32), 5228–5236 (2010).
   PubMed Web of Science ®Google Scholar
• Strike C, Rufo C. Embarrassing, degrading, or beneficial: patient and staff perspectives on urine drug testing in methadone maintenance treatment. J. Substance Use15(5), 303–312 (2010).
   Web of Science ®Google Scholar
• Treloar C, Fraser S, Valentine K. Valuing methadone take-away doses: the contribution of service user perspectives to policy and practice. Drugs (Abingdon Engl.)14(1), 61–74 (2007).
   Google Scholar
• Bailey S, Ouellet L, Mackesy-Amiti M et al. Perceived risk, peer influences, and injection partner type predict receptive syringe sharing among young adult injection drug users in five U.S. cities. Drug Alcohol Depend.91, S18–S29 (2007).
   PubMed Web of Science ®Google Scholar
• Jackson L, Parker J, Dykeman M, Gahagan J, Karabanow J. The power of relationships: implications for safer and unsafe practices among injection drug users. Drugs (Abingdon Engl.)17(3), 189–204 (2010).
   Google Scholar
• Loxley W, Ovenden C. Friends and lovers: needle sharing in young people in Western Australia. AIDS Care7(3), 337–351 (1995).
   PubMed Web of Science ®Google Scholar
• Smyth BP, Roche A. Recipient syringe sharing and its relationship to social proximity, perception of risk and preparedness to share. Addictive Behaviours32, 1943–1948 (2007).
   PubMed Web of Science ®Google Scholar
• Unger JB, Kipke MD, De Rosa CJ, Hyde J, Ritt-Olsen A, Montgomery S. Needle-sharing among young IV drug users and their social network members: the influence of the injection partner’s characteristics on HIV risk behavior. Addictive Behaviours31(9), 1607–1618 (2006).
   PubMed Web of Science ®Google Scholar
• Rhodes T, Quirk A. Drug users’ sexual relationships and the social organisation of risk: the sexual relationship as a site of risk management. Soc. Sci. Med.46, 157–169 (1998).
   PubMed Web of Science ®Google Scholar
• Taylor A, Fleming A, Rutherford J, Goldberg D. Effective Interventions Unit Examining the Injecting Practices of Injecting Drug Users in Scotland. Scottish Centre for Infection and Environmental Health, Edinburgh, UK (2004).
   Google Scholar
• Dwyer R, Fraser S, Treloar C. Doing things together?: analysis of health promotion materials to inform hepatitis C prevention among couples. Addiction Res. Theory (2010) (In Press).
   Google Scholar
• Cavacuiti CA. You, me…and drugs – a love triangle: important considerations when both members of a couple are abusing substances. Substance Use and Misuse39(4), 645–656 (2004).
   PubMed Web of Science ®Google Scholar
• Simmons J, Singer M. I love you…and heroin: care and collusion among drug-using couples. Substance Abuse Treatment, Prevention and Policy1, 7 (2006).
   PubMed Web of Science ®Google Scholar
• Keane H. Critiques of harm reduction, morality and the promise of human rights. Int. J. Drug Policy14, 227–232 (2003).
   Google Scholar
• Lenton E, Fraser S, Moore D, Treloar C. Hepatitis C, love and intimacy: beyond the ‘anomalous body’. Drugs: Education, Prevention and Policy (2010) (In Press).
   Google Scholar
• Hunt N, Stillwell G, Taylor C, Griffiths P. Evaluation of a brief intervention to prevent initiation into injecting. Drugs (Abingdon Engl.)5(2), 185–94 (1998).
   Google Scholar
• Kreuter M, Wray R. Tailored and targeted health communication: strategies for enhancing information relevance. Am. J. Health Behavior27(Suppl. 3), S227–S232 (2003).
   PubMed Web of Science ®Google Scholar
• Kreuter MW, Oswald DL, Bull FC, Clark EM. Are tailored health education materials always more effective than non-tailored materials? Health Education Res.15(3), 305–315 (2000).
   PubMed Web of Science ®Google Scholar
• Noar SM, Benac CN, Harris MS. Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychol. Bull.133(4), 673–693 (2007).
   PubMed Web of Science ®Google Scholar
• Sheridan J, Wheeler A, Walters C. Health problems and help-seeking activities of methadone maintenance clients at Auckland Methadone Service (AMS): potential for community pharmacy service expansion? Harm Reduct. J.2, 25 (2005).
   PubMedGoogle Scholar
• Sheridan J, Aggleton M, Carson T. Public dental health: dental health and access to dental treatment: a comparison of drug users and non-drug users attending community pharmacies. Brit. Dent. J.191, 453–457 (2001).
   PubMed Web of Science ®Google Scholar
• Kent G, Johns R. Psychological effects of permanently implanted false teeth: a 2-year follow-up and comparison with dentate patients. Psychol. Health8, 213–222 (1993).
   Web of Science ®Google Scholar
• Madden A, Bath N, Byrne J. It’s all smoke screens and mirrors: self-determination, representation and identity from the drug user’s perspective. In: Evolving Knowledge and Practice: 11th Social Research Conference on HIV, Hepatitis C and Related Diseases. National Centre in HIV Social Research, Sydney, Australia (2010).
   Google Scholar
• Treloar C, Fraser S. Public opinion on NSPs: avoiding assumptions for policy and practice. Drug Alcohol Rev.26(4), 355–361 (2007).
   PubMed Web of Science ®Google Scholar
• Treloar C, Korner H. NSPs and the media: a case study of balanced and accurate reporting. Aust. NZ J. Public Health29(5), 489–490 (2005).
   PubMed Web of Science ®Google Scholar
• Crofts N, Aitken C, Kaldor JM. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not. Med. J. Aust.170, 220–221 (1999).
   PubMed Web of Science ®Google Scholar